Skip to main content
. 2018 Feb 5;9:33. doi: 10.3389/fneur.2018.00033

Figure 3.

Figure 3

Simultaneous fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET)-MRI of a glioblastoma. (A) Contrast-enhanced axial MR image demonstrating a heterogeneously enhancing mass in the corpus callosum. (B) Co-registered PET-MR image accurately demonstrating that the focus of elevated FDG avidity corresponds to the solidly enhancing component. (C) FDG PET image, without co-registration with MRI, demonstrates a focus of elevated FDG-avidity. No copyright permissions were required for use of these images.